Carvedilol 6.25mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Carvedilol

Available from:

Almus Pharmaceuticals Ltd

ATC code:

C07AG02

INN (International Name):

Carvedilol

Dosage:

6.25mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02040000; GTIN: 05060057402726

Patient Information leaflet

Accord Logo
CARVEDILOL 3.125MG TABLETS
CARVEDILOL 6.25MG TABLETS
CARVEDILOL 12.5MG TABLETS
CARVEDILOL 25MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU
.
•
Keep the leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
WHAT ARE CARVEDILOL TABLETS AND WHAT THEY ARE USED FOR
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE CARVEDILOL TABLETS
3.
HOW TO TAKE CARVEDILOL TABLETS
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE CARVEDILOL TABLETS
6.
CONTENTS OF THE PACK AND OTHER INFORMATION
1. WHAT CARVEDILOL TABLETS IS AND WHAT IT IS USED FOR
Carvedilol Tablets contain the active ingredient carvedilol.
Carvedilol is one of a group of medicines
called beta-blockers. These medicines work by widening blood vessels
(vasodilation). This lowers blood
pressure and makes it easier for the heart to pump blood around the
body by lessening the strain on the
heart muscles.
Carvedilol Tablets may be used to treat:
•
High blood pressure (hypertension)
•
Angina pectoris
•
Heart failure. Carvedilol Tablets are normally taken at the same time
as other medicines for heart
failure.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE
Carvedilol Tablets
DO NOT TAKE
Carvedilol Tablets
:
•
If you have ever had an allergic reaction to Carvedilol Tablets or any
of the ingredients in the tablet.
An allergic reaction may include a rash, itching, difficulty breathing
or swelling of the face, lips,
throat or tongue.
•
If you have a history of wheezing due to asthma, emphysema or
bronchitis.
•
If you have severe liver problems.
•
If you suffer from a weak heart (cardiogenic shock) or sec

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Carvedilol 6.25 mg tablet
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
One film-coated tablet contains 6.25 mg carvedilol.
Excipient with known effect: Each tablet contains 25mg lactose
monohydrate
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Film-coated tablet
White, oval, scored on both sides and marked "6.25" on one side. The
tablet
can be divided into equal halves.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Essential hypertension.
Chronic stable angina pectoris
Adjunctive treatment in moderate to severe stable heart failure._ _
_4.2 _
_POSOLOGY AND METHOD OF ADMINISTRATION _
Posology
Carvedilol is available in 4 strengths: 3.125 mg, 6.25 mg, 12.5 mg and
25 mg
_Essential hypertension _
Carvedilol may be used for the treatment of hypertension alone or in
combination
with other antihypertensives, especially thiazide diuretics. Once
daily dosing is
recommended, however the recommended maximum single dose is 25 mg and
the
recommended maximum daily dose is 50 mg.
_Adults _
The recommended initial dose is 12.5 mg once a day for the first two
days. Thereafter,
the treatment is continued at the dose 25 mg/day. If necessary, the
dose may be further
increased gradually at intervals of two weeks or more rarely.
_Elderly_
The recommended initial dose in hypertension is 12.5 mg once a day,
which may also
be sufficient for continued treatment. However, if the therapeutic
response is
inadequate at this dose, the dose may be further increased gradually
at intervals of two
weeks or more rarely.
_Chronic stable angina pectoris _
_Adults_
The recommended initial dose is 12.5 mg twice daily for two days.
Thereafter, the
treatment is continued at the dose 25 mg twice daily. If necessary,
the dose may be
further increased gradually at intervals of two weeks or more rarely.
The
recommended maximum daily dose is 100 mg in divided doses (50mg twice
daily).
_Elderly_
The recommended initial dose is 12.5 mg twice daily for two days.
There